President-elect Donald Trump has promised a crackdown on illegal immigration and significant changes to immigration laws. Now his advisers will contend with long-existing headwinds to turn Trump's campaign rhetoric into policy.
Here are five major roadblocks the incoming administration will face:
Immigration-court backlog
Most immigrants in the U.S. illegally can't be deported without a hearing in immigration court, where they have a chance to ask for asylum or another avenue to stay in the country. But immigration courts are so backlogged that hearings are being scheduled as far into the future as 2029.
While immigrants wait for their hearings, they are given work permits, allowing them to find legal employment inside the U.S. Trump and his allies argue this process is an important factor attracting migrants to come to the U.S. to seek asylum—even if they don't win their court cases.
Outside experts estimate that Congress would have to hire about 5,000 immigration judges—the system now has roughly 500—to efficiently sort through all existing cases as well as new ones.
Barring a large infusion of cash to hire more judges, the Trump administration could shuffle around whose hearings happen first, giving priority to people from certain countries or those with criminal histories. They could make it tougher for immigrants to delay their final hearings, which judges sometimes allow in some cases, to give immigrants more time to find lawyers to represent them.
Without a change in the law, most of the migrants who entered the country illegally during President Biden's term won't be legally deportable for years.
Lack of ICE agents
Diese Geschichte stammt aus der January 02, 2025-Ausgabe von Mint Bangalore.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der January 02, 2025-Ausgabe von Mint Bangalore.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars
Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects
DIAL drops plea over Hindon ops expansion
Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.
Auto sales rise 9% in 2024 despite headwinds: Fada
Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec
Razorpay Charts Return to India; Eyes Expansion, IPO
Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years
Bank profits set to moderate in FY26 as bad assets rise
Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier
Lloyds Metals shines on likely gains from acquisition, capex
Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.
Another tough year for FMCG?
Feeling blue
Your fancy, new ETF might be a little too fancy
Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good
Risks to economy escalating in 2025, cautions SBICAPS
Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report
Intas Pharma bags another overseas company
Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.